SCHEMBL1775494

SCHEMBL1775494

O=S(=O)(Nc1ccc(OC2CCNC2)c2ccccc12)c1ccc(Cl)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 1/20 0.42
HTR6 P50406 2/20 0.41
MCOLN3 Q8TDD5 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 3/20 0.41
CCR2 P41597 1/20 0.41
HTT P42858 3/20 0.40
RECQL P46063 2/20 0.38
PSEN1 P49768 2/20 0.38
PSEN2 P49810 2/20 0.38
APH1B Q8WW43 2/20 0.38
NCSTN Q92542 2/20 0.38
APH1A Q96BI3 2/20 0.38
PSENEN Q9NZ42 2/20 0.38
HSP90AB1 P08238 2/20 0.38
TOP2A P11388 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1774599 0.99 PTGES2 (0.42) PTGES2HTR6MCOLN3ALDH1A1MEN1
SCHEMBL1775259 0.94 PTGES2 (0.44) PTGES2HTR6MCOLN3ALDH1A1MEN1
Hydrochloric Acid SCHEMBL1774696 0.93 PTGES2 (0.43) PTGES2HTR6MCOLN3ALDH1A1MEN1
SCHEMBL1776585 0.82 HKDC1 (0.51) ALDH1A1HTR2CHTR2B
SCHEMBL1777498 0.82 HKDC1 (0.51) ALDH1A1HTR2CHTR2B
SCHEMBL1774701 0.82 HKDC1 (0.51) ALDH1A1HTR2CHTR2B
Hydrochloric Acid SCHEMBL1775345 0.82 HKDC1 (0.50) HSP90AB1TOP2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL1775808 0.82 HKDC1 (0.50) HSP90AB1TOP2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL1775351 0.82 HKDC1 (0.50) HSP90AB1TOP2AHTR2CHTR2B
SCHEMBL1775632 0.80 CCR2 (0.45) PTGES2HTR6MCOLN3ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943639-B2 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss PROXIMAGEN LIMITED (GB) 2011-05-17 US claimed
EP-1513828-A1 NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS Biovitrum AB (SE) 2005-03-16 EP disclosed
WO-2004000828-A1 NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS BIOVITRUM AB (SE) 2003-12-31 WO disclosed